Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 8, Issue 5, Pages 361-367Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd2872
Keywords
-
Ask authors/readers for more resources
The potential cardiovascular risks that are associated with drugs for type 2 diabetes have recently raised considerable clinical and regulatory concerns. As some risk factors for cardiovascular disease and type 2 diabetes are related, identifying agents that target shared underlying pathways and processes is an attractive therapeutic strategy. In this article, we review the background to and the implications of recent regulatory guidance on the development of new drugs for diabetes, and discuss the potential cardiovascular effects of selected classes of diabetes drugs that are currently being investigated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available